Health · 1 sources covering this

Texas doctor charged in $89M fraud case as administration pushes health care crackdown

The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing insurers for medically unnecessary cardiovascular screening tests.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
Texas doctor charged in $89M fraud case as administration pushes health care crackdown
The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing insurers for medically unnecessary cardiovascular screening tests.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/199e2e6956e632456b24bfb6ee7358c0020633d9"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Texas doctor charged in $89M fraud case as administration pushes health care crackdown"></iframe>

Texas doctor charged in $89M fraud case as administration pushes health care crackdown

How 1 sources are covering this

Texas doctor charged in $89M fraud case as administration pushes health care crackdown

More from Health

STAT+: Exclusive: Mystery man gets experimental GLP-1

STAT+: Pharmalittle: We’re reading about FDA reforming clinical trials, a Pfizer setback, and much more news

STAT+: Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program

STAT+: OpenEvidence will add FDA-cleared AI to detect heart disease

Reader

Trust & legal

Across the network

How 1 sources are covering this

Texas doctor charged in $89M fraud case as administration pushes health care crackdown

More from Health

STAT+: Exclusive: Mystery man gets experimental GLP-1

STAT+: Pharmalittle: We&#8217;re reading about FDA reforming clinical trials, a Pfizer setback, and much more news

STAT+: Lilly&#8217;s retatrutide has been offered to a single person via &#8216;compassionate use&#8217; program

STAT+: OpenEvidence will add FDA-cleared AI to detect heart disease

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about FDA reforming clinical trials, a Pfizer setback, and much more news

STAT+: Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program